ENOX1 and neoplasm: To address the question of whether the survival of tumor-bearing mice could be increased by Enox1 targeting in tumor stroma during fractionated radiation therapy, HT-29 xenografts were administered 2 Gy x 4 q.d. in the absence or presence of an Enox1 small molecule inhibitor.